Loss of heterozygosity related to TMB and TNB may predict PFS for patients with SCLC received the first line setting

• Chenyue Zhang,
• Kai Wang,
• Haiyong Wang

Affiliations

Chenyue Zhang

Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai Medical College

Kai Wang

Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University

Haiyong Wang

Department of Internal Medicine Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences